BackNexalin Technology- Warrants (15/09/2025) Overview

Nexalin Technology- Warrants (15/09/2025) Research & Development

Research & Development expenses for NXLIW.

Quarterly R&D Expenses

$346382.00
14.74% YoY

As of Mar 31, 2026

Annual R&D Expenses (TTM)

$1.02M
22.58% YoY

Trailing 12 months ending Mar 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)